[if gte mso 9] > < xml > normal 0 21 false false false MicrosoftInternetExplorer4 <!-[if gte mso 9] > < w:LatentStyles DefLockedState = “false” LatentStyleCount = “156” > <!-[if gte mso 10] >

show that the absence of symptoms in sleep apneaalso hides cardiovascular risk

published in the prestigious research ‘ Journal of theAmerican Medical Association ’

-an investigation of the University Hospital of Álava incollaboration with other 13 Spanish hospitals concludes that patients whohave no drowsiness have the same risks as other.

– the study has been made with over 700 patients with amoderado-grave table of four years sleep apneas.

– until now, was accepted by the scientific communitythat apnea of soil were only when she came accompanied of thesymptoms ”, explains Dr. Duran, Hospital Research serviceUniversity of Alava and one of themajor coordinators of this work.

-treatment with CPAP (the machine which introduces air to)(pressure in the throat preventing apneas) significantly reduces theappearance of cardiovascular complications.

– the results of this research are published today in theprestigious ‘ Journal of the American Medical Association (JAMA) ’, an of themedical journals more dissemination and prestige have globally, and whereonly published studies involving a change in patterns ofthe medical community’s work.

vitoria, may 2012- the sleep apnea is a disease veryfrequent which affects 25% of the population slightly and between a 3 and a7% of severe form, which consists in the obstruction of the tract respiratoryduring sleep, causing to be momentarily stop breathing,being able to get to cause cardiovascular disease and stroke.Currently, the sleep apnea is treated only when you have symptoms,drowsiness mainly. However, a survey conducted bythe University Hospital of Alava, in collaboration with other 13 hospitalsSpanish ** and the Fundación Vasca de Innovación e Investigación Sanitarias (BIOEF),It has been shown that sleep apnea patients that have no symptomsthey run the same risks of suffering from cardiovascular complications(high blood pressure, cardiovascular disease and/or complications)(cardiovascular) who do them are.

the importance of this discovery is such that even hascaptured the interest of the Journal of the American Medical Association (JAMA), whichThis research includes in its latest issue, published today. This is one ofthe medical journals more dissemination and prestige have globally, andwhere only published studies involving a change in patterns ofthe medical community’s work. In fact, the diagnosis of sleep apneaIt is key, not only in order to apply a treatment in time, but alsobecause not diagnose these patients twice that healthcare costsThese people generate.

to reach this conclusion, the Working Group hasconducted a comprehensive study in 725 patients who have been followed duringfour years. Design was a study which included only patients thatthey had at least 20 apneas per hour of sleep (which is a table)(moderado-grave), but did not have any symptoms measured by sleepiness;the main objective was to measure the occurrence of complicationscardiovascular ”, says Joaquín Durán-Cantolla of the research servicethe University Hospital of Alava and one of the main coordinators of theI am a student.

patients were also divided into two groups. AGroup received treatment with CPAP (continuous positive airway pressure), themachine which introduces air pressure in the throat preventing apneas and thatis the main treatment of this disease (in Spain is used)(by about 300,000 people). The other group did not receive CPAP. Both groups areThey also discussed with General measures to improve sleep and reduce theweight (higiénico-dietéticas action). Although analyzed globally not beThey demonstrated differences between the two groups, those who received CPAP hada significant reduction in the appearance of cardiovascular complicationscompared with the other ”, said Duran-Cantolla. This study is the largestclinical trial undertaken so far to assess the effect of CPAP onpatients with no symptoms sleep apnea

** hospitals who have participated in the study are: IRBLleida (Lleida), Hospital Universitario de Alava (Vitoria), Hospital our Lady of theRocío (Sevilla), Hospital Universitario Son Dureta (Palma de Mallorca),Hospital Sant Joan (Alicante), Hospital San Pedro de Alcántara (Cáceres)Hospital Marqués de Valdecilla (Santander), Hospital Miguel Servet (Zaragoza),Hospital Universitario La Paz (Madrid), Hospital 12 de Octubre (Madrid), HospitalGeneral Yagüe (Burgos), Hospital Sant Pau (Barcelona), Hospital de Bellvitge(Barcelona), Hospital Rio Hortega (Valladolid) and Hospital Clínic (Barcelona).